EZCORP has rallied hard — up 28% over the past month — and short sellers are quietly retreating.
Short interest has fallen sharply, dropping to 18.6% of the free float from above 22% in mid-March. That is a meaningful unwind: the position peaked near 22.5% in late March and has now shed roughly 3.5 percentage points. The week alone saw short interest fall 5.7%. With days to cover running at nearly 25 according to official FINRA data, any further rapid covering could create additional fuel for the move already underway.
The lending market tells a nuanced story. Borrow availability is in the tight-to-normal range, which limits squeeze pressure but does not remove it entirely. Cost to borrow has nudged up about 21% over the past week to around 0.56% — still a modest rate in absolute terms, well short of levels that signal genuine borrow stress. The options market is equally relaxed. The put/call ratio of 0.147 is slightly below its 20-day average of 0.153, and at 1.2 standard deviations below that mean it leans modestly bullish. The 52-week range on the PCR stretches from 0.09 to 2.12, so the current reading sits well toward the call-heavy end — options traders are not hedging this rally.
Canaccord Genuity is the clearest bull on the Street. On April 7 the firm raised its price target to $40 from $34 while keeping its Buy rating. That target now sits about 24% above the current price of $32.28. Stephens & Co. holds a more cautious stance with an Equal-Weight rating, a target at $26 — well below where the stock now trades — reflecting the bear case that inventory turnover is lagging, merchandise aging is a concern, and gold-price volatility creates earnings risk. The mean analyst target is $34, implying just 5% upside from current levels, though the Canaccord target of $40 offers more runway for believers. Valuation has re-rated alongside the stock: the P/E multiple has expanded roughly 3.5 points over the past 30 days to around 16.9x. The EV/EBITDA at 9.1x is broadly stable. The ORTEX short score of 79.2 places in the top percentile of the universe for short interest pressure — a persistent structural feature of this name rather than a new development.
Insider activity from late February and early March is worth noting, though not as a bullish signal. Several insiders sold into the then-lower price levels in the $24–$27 range: two independent directors, the Chief Legal Officer, a C-level officer, and the Chief Internal Audit Officer collectively sold around $2.1 million worth of stock between mid-February and early March. The 90-day net insider figure is slightly positive due to a CEO award of shares, but the cash sales cluster looks like routine profit-taking at a time when the stock was already running. The CEO and CFO also sold in November 2025 near $17.82. BlackRock and FMR (Fidelity) are the top institutional holders with roughly 11% each; FMR added more than 2 million shares in the quarter ending March 31, a material increase.
Earnings history adds context to the valuation debate. The most recent print in late March produced only a modest 1.5% negative one-day move, but the prior quarter — reported in February — delivered a 16.7% single-day gain and a 10.8% five-day follow-through. The bull case cites record quarterly results, an 11% sales increase, 28% Latin America EBITDA growth, and improving merchandise margins. The bear case counters with inventory turnover running at roughly 2.3x, a higher proportion of slower-moving jewelry, and currency exposure across its Latin American operations.
Closest peer FCFS (FirstCash Holdings, correlation 60%) rose 4.9% over the same week — broadly in line with EZPW's 6.2% move. Consumer finance peers LC and UPST moved in the other direction, falling 6.9% and 12.3% respectively on the week, highlighting the divergence between pawn-model operators and fintech lenders in the current environment. With no next earnings event yet confirmed in the calendar, the next catalyst to watch is whether the short covering pace holds or reverses as the stock approaches and then tests the Canaccord $40 target.
See the live data behind this article on ORTEX.
Open EZPW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
